Literature DB >> 21875872

Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.

Maciej Lech1, Claudia Kantner, Onkar P Kulkarni, Mi Ryu, Ekaterina Vlasova, Jürgen Heesemann, David Anz, Stefan Endres, Koichi S Kobayashi, Richard A Flavell, Javier Martin, Hans-Joachim Anders.   

Abstract

OBJECTIVES: Interleukin-1 receptor-associated kinase (IRAK)-M suppresses Toll-like receptor (TLR)-mediated activation of innate immunity during infection. A similar role was hypothesised for IRAK-M in autoimmunity.
METHODS: Irak-m-deficient mice were crossed with autoimmune C57BL/6-lpr/lpr mice and detailed phenotype analysis was performed.
RESULTS: Irak-m deficiency converted the mild autoimmune phenotype of C57BL/6-lpr/lpr mice into a massive lymphoproliferative syndrome with lethal autoimmune lung disease and lupus nephritis. Irak-m deficiency induced a number of interferon-related genes, cytokines and plasma cell survival factors in spleen cells of these mice. Irak-m-deficient C57BL/6-lpr/lpr mice showed expansion of autoreactive T cells, dysfunctional regulatory T cells and plasma cells which was associated with increased lupus autoantibody production. TLR7 antagonism almost completely abrogated this phenotype consistent with IRAK-M-mediated suppression of TLR7 signalling in vitro.
CONCLUSIONS: These data identify a previously unknown function of IRAK-M-namely, suppression of TLR7-mediated autoimmunity-and mutant IRAK-M as a previously unknown genetic risk for murine SLE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21875872     DOI: 10.1136/ard.2011.155515

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups.

Authors:  Kenneth M Kaufman; Jian Zhao; Jennifer A Kelly; Travis Hughes; Adam Adler; Elena Sanchez; Joshua O Ojwang; Carl D Langefeld; Julie T Ziegler; Adrienne H Williams; Mary E Comeau; Miranda C Marion; Stuart B Glenn; Rita M Cantor; Jennifer M Grossman; Bevra H Hahn; Yeong Wook Song; Chack-Yung Yu; Judith A James; Joel M Guthridge; Elizabeth E Brown; Graciela S Alarcón; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Luis M Vilá; Juan-Manuel Anaya; Susan A Boackle; Anne M Stevens; Barry I Freedman; Lindsey A Criswell; Bernardo A Pons Estel; Joo-Hyun Lee; Ji-Seon Lee; Deh-Ming Chang; R Hal A Scofield; Gary S Gilkeson; Joan T Merrill; Timothy B Niewold; Timothy James Vyse; Sang-Cheol Bae; Marta E Alarcón-Riquelme; Chaim O Jacob; Kathy Moser Sivils; Patrick M Gaffney; John B Harley; Amr H Sawalha; Betty P Tsao
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

Review 2.  A novel pathogenetic concept-antiviral immunity in lupus nephritis.

Authors:  Adriana Migliorini; Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2012-01-17       Impact factor: 28.314

Review 3.  Cellular and molecular mechanisms involved in the resolution of innate leukocyte inflammation.

Authors:  Allison Rahtes; Shuo Geng; Christina Lee; Liwu Li
Journal:  J Leukoc Biol       Date:  2018-04-24       Impact factor: 4.962

4.  Studying IFN-gamma, IL-17 and FOXP3 in pediatric lupus nephritis.

Authors:  Mutlu Uysal Yazici; Diclehan Orhan; Gulsev Kale; Nesrin Besbas; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2014-01-31       Impact factor: 3.714

5.  Deficiency in IRAK4 activity attenuates manifestations of murine Lupus.

Authors:  Michael Murphy; Goutham Pattabiraman; Tissa T Manavalan; Andrei E Medvedev
Journal:  Eur J Immunol       Date:  2017-03-31       Impact factor: 5.532

Review 6.  Pattern recognition receptors and the inflammasome in kidney disease.

Authors:  Jaklien C Leemans; Lotte Kors; Hans-Joachim Anders; Sandrine Florquin
Journal:  Nat Rev Nephrol       Date:  2014-06-03       Impact factor: 28.314

Review 7.  The future of uveitis treatment.

Authors:  Phoebe Lin; Eric B Suhler; James T Rosenbaum
Journal:  Ophthalmology       Date:  2013-10-26       Impact factor: 12.079

8.  The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction.

Authors:  Amit Saxena; Arti V Shinde; Zaffar Haque; Yi-Jin Wu; Wei Chen; Ya Su; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2015-11-02       Impact factor: 5.000

9.  Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy.

Authors:  Maciej Lech; Regina Gröbmayr; Mi Ryu; Georg Lorenz; Ingo Hartter; Shrikant R Mulay; Heni Eka Susanti; Koichi S Kobayashi; Richard A Flavell; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 10.121

10.  IRF5 Is Required for Bacterial Clearance in Human M1-Polarized Macrophages, and IRF5 Immune-Mediated Disease Risk Variants Modulate This Outcome.

Authors:  Matija Hedl; Jie Yan; Heiko Witt; Clara Abraham
Journal:  J Immunol       Date:  2018-12-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.